☆ 4.1 Review

Treatment for cognitive and neuropsychiatric non-motor symptoms in Parkinson's disease: current evidence and future perspectives

EXPERT REVIEW OF NEUROTHERAPEUTICS (2023)

Related references

Note: Only part of the references are listed.
Review Neurosciences

Advances in the Pharmacological and Non-pharmacological Management of Non-motor Symptoms in Parkinson's Disease: An Update Since 2017

Daniel J. van Wamelen et al.

Summary: This study aimed to provide an updated review on advances in pharmacological, non-pharmacological, and exercise-based interventions for non-motor symptoms (NMS) in Parkinson's disease (PD). The study found that since 2017, new strategies for managing NMS have emerged, such as the use of droxidopa for orthostatic hypotension, various dopaminergic treatment options for insomnia, and a range of non-pharmacological and exercise-based interventions for cognitive and neuropsychiatric symptoms, pain, and insomnia and excessive sleepiness. The conclusion is that targeted non-pharmacological treatments and other NMS management options may have a significant beneficial effect on the quality of life and should be considered in the treatment pathways of PD.

CURRENT NEUROPHARMACOLOGY (2023)

Add to Collection
Review Cell Biology

Subjective cognitive decline in idiopathic Parkinson′s disease: A systematic review

Christiane Oedekoven et al.

Summary: Cognitive symptoms of Parkinson's disease (PD) are highly disabling non-motor features of the disease. The concept of subjective cognitive decline (SCD) has gained interest for earlier detection of cognitive decline in PD.

AGEING RESEARCH REVIEWS (2022)

Add to Collection
Review Neurosciences

Selective 5HT3 antagonists and sensory processing: a systematic review

Eirini Tsitsipa et al.

Summary: This article reviewed human studies evaluating the effects of Ondansetron and other 5-HT3 receptor antagonists on sensory gating deficits or sensory processing. The results showed that Ondansetron and tropisetron improved sensory gating in patients with schizophrenia, and tropisetron also improved sustained visual attention in non-smoking patients.

NEUROPSYCHOPHARMACOLOGY (2022)

Add to Collection
Review Psychology, Clinical

Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression

Elizabeth R. Wallace et al.

Summary: This study conducted a meta-analysis on PD-MCI patients and found significant differences in cognitive test performance, with cognitive screeners showing the most pronounced effect. In the progression from PD-MCI to PDD, executive dysfunction exhibits a significant impact.

NEUROPSYCHOLOGY REVIEW (2022)

Add to Collection
Review Pharmacology & Pharmacy

Comparative efficacy and acceptability of drug treatments for Parkinson's disease with depression: A systematic review with network meta-analysis

Xiao-Le Wang et al.

Summary: This systematic review and network meta-analysis evaluated the drug treatments for depressed Parkinson's disease (dPD). The results showed that dopamine agonists (DOP) and selective serotonin reuptake inhibitors (SSRI) had good efficacy in improving symptoms compared with placebo. Both direct and indirect evidence supported the use of DOP, monoamine-oxidase inhibitors, serotonin-norepinephrine reuptake inhibitors, SSRI, and tricyclic antidepressants for improving depressive symptoms in dPD. However, the adverse effects of DOP and SSRI need to be closely monitored.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

Add to Collection
Article Psychiatry

Mortality Among Parkinson's Disease Patients Treated With Pimavanserin or Atypical Antipsychotics: An Observational Study in Medicare Beneficiaries

Andrew D. Mosholder et al.

Summary: This study compared mortality rates between pimavanserin and atypical antipsychotics in patients with Parkinson's disease. The results showed that pimavanserin had a lower mortality rate than atypical antipsychotics during the first 180 days of treatment, but this advantage was observed only in community-dwelling patients, not nursing home residents.

AMERICAN JOURNAL OF PSYCHIATRY (2022)

Add to Collection
Review Neurosciences

Brain microstructural alterations of depression in Parkinson's disease: A systematic review of diffusion tensor imaging studies

Mohammad Amin Salehi et al.

Summary: Depression is a common psychiatric problem among Parkinson's disease patients, and both conditions are associated with microstructural anomalies in the brain. Research has revealed that depressed Parkinson's disease patients exhibit abnormalities in specific cortical regions and limbic structures.

HUMAN BRAIN MAPPING (2022)

Add to Collection
Review Clinical Neurology

Morphological basis of Parkinson disease-associated cognitive impairment: an update

Kurt A. Jellinger

Summary: Cognitive impairment is a significant non-motor symptom of Parkinson's disease, with a wide range of cognitive dysfunctions observed. Modern neuroimaging studies have revealed notable changes in gray and white matter in PD patients with cognitive impairment. Combined analysis of imaging and fluid markers shows promise in identifying PD-MCI and PDD.

JOURNAL OF NEURAL TRANSMISSION (2022)

Add to Collection
Review Behavioral Sciences

Prevalence and clinical aspects of depression in Parkinson's disease: A systematic review and meta-analysis of 129 studies

Shengri Cong et al.

Summary: Depression is an independent and frequent non-motor symptom in Parkinson's disease (PD), appearing in the early stage and persisting throughout the disease duration. It is associated with several clinical characteristics and other symptoms that negatively impact on quality of life.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2022)

Add to Collection
Article Medicine, General & Internal

Trial of Cinpanemab in Early Parkinson's Disease

A. E. Lang et al.

Summary: In participants with early Parkinson's disease, the effects of cinpanemab on clinical measures of disease progression and changes in DaT-SPECT imaging did not differ from those of placebo over a 52-week period.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection
Review Pharmacology & Pharmacy

Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review

Thomas J. Moore et al.

Summary: Ketamine and esketamine, as novel treatments for depression and psychiatric disorders, induce a transient altered mental state by blocking the NMDA receptor. This multidisciplinary review evaluates the pharmacology, effectiveness, and safety of these drugs, and raises substantial questions about their use for psychiatric disorders based on evidence from various sources.

PHARMACOTHERAPY (2022)

Add to Collection
Review Neurosciences

Apathy in Parkinson's Disease: Defining the Park Apathy Subtype

Segolene De Waele et al.

Summary: This article summarizes the research findings on apathy in Parkinson's disease, discusses the prevalence rates and screening tools, formulates patient-tailored treatment recommendations, and explores the clinical manifestations and prognosis of the Park apathy phenotype. It aims to provide a clinical and patient-oriented perspective on the vast theoretical knowledge available.

BRAIN SCIENCES (2022)

Add to Collection
Article Neurosciences

Effects of MAO-B inhibitors on non-motor symptoms and quality of life in Parkinson's disease: A systematic review

Takashi Tsuboi et al.

Summary: Selegiline, rasagiline, and safinamide, three MAO-BIs drugs, have different effects on the quality of life and non-motor symptoms of patients with Parkinson's disease. However, the understanding of these effects is still unclear and further high-quality studies are needed to verify them.

NPJ PARKINSONS DISEASE (2022)

Add to Collection
Review Cell Biology

Computerized cognitive training in Parkinson's disease: A systematic review and meta-analysis

Hanna M. Gavelin et al.

Summary: Cognitive impairment is a common symptom in Parkinson's disease (PD) patients, and computerized cognitive training (CCT) may have beneficial effects on their cognitive and psychosocial functioning. This study found that CCT had a significant positive effect on overall cognitive function and clinical measures of global cognition in PD patients, especially those with mild cognitive impairment. The dose of CCT and the presence of mild cognitive impairment in PD patients were associated with larger effect sizes. There was no significant difference in efficacy between home-based and supervised training.

AGEING RESEARCH REVIEWS (2022)

Add to Collection
Review Clinical Neurology

Neuroimaging of Anxiety in Parkinson's Disease: A Systematic Review

Guillaume Carey et al.

Summary: Anxiety symptoms in Parkinson's disease are associated with structural and functional changes in the fear and limbic cortico-striato-thalamocortical circuits. The neuropathology of PD may affect these circuits in different ways, which explains the high prevalence of anxiety and associated symptoms in PD.

MOVEMENT DISORDERS (2021)

Add to Collection
Article Clinical Neurology

Subjective cognitive Complaints in early Parkinson ' s disease patients with normal cognition are associated with affective symptoms

Cong Yang Chua et al.

Summary: Subjective cognitive complaints (SCC) and affective symptoms are highly prevalent in early Parkinson's Disease (PD), with SCC significantly associated with anxiety, depression, and apathy in cognitively normal PD participants. Such an association was not found in cognitively impaired PD participants, suggesting that SCC in cognitively normal PD patients may indicate an underlying affective disorder.

PARKINSONISM & RELATED DISORDERS (2021)

Add to Collection
Review Geriatrics & Gerontology

Past, Present, and Future of Non-invasive Brain Stimulation Approaches to Treat Cognitive Impairment in Neurodegenerative Diseases: Time for a Comprehensive Critical Review

Clara Sanches et al.

Summary: Research has shown that non-invasive brain stimulation (NIBS) may help limit cognitive decline associated with neurodegenerative conditions, but the current clinical evidence is not yet sufficient to demonstrate its therapeutic benefit and clinical significance. Therefore, more double-blind placebo-controlled randomized clinical trials and reliable biomarkers are needed to strengthen the research.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Add to Collection
Article Clinical Neurology

The efficacy of repetitive transcranial magnetic stimulation on emotional processing in apathetic patients with Parkinson's disease: A Placebo-controlled ERP study

Wei Wei et al.

Summary: The study revealed that stimulating the right DLPFC with HF-rTMS can improve emotional processing in both apathetic and non-apathetic PD patients, but with differing sensitivities and distinct neurophysiological characteristics.

JOURNAL OF AFFECTIVE DISORDERS (2021)

Add to Collection
Review Endocrinology & Metabolism

Cellular and molecular pathophysiology in the progression of Parkinson's disease

Vandana Zaman et al.

Summary: Parkinson's disease is a neurodegenerative disorder linked to the loss of dopaminergic neurons in the substantia nigra. The disease's etiology is still unclear, but interactions between external and internal factors may play a crucial role in its onset and progression. Research in animal models and post-mortem human tissue has identified cellular and molecular changes in the diseased brain, indicating complex interactions between different glial cell types and molecular pathways.

METABOLIC BRAIN DISEASE (2021)

Add to Collection
Article Clinical Neurology

Cognitive Behavioral Therapy for Anxiety in Parkinson's Disease: A Randomized Controlled Trial

Anja J. H. Moonen et al.

Summary: This study assessed the effectiveness of cognitive behavioral therapy (CBT) in treating anxiety in patients with Parkinson's disease. Results showed that CBT is an effective treatment for reducing situational and social anxiety, as well as avoidance behavior.

MOVEMENT DISORDERS (2021)

Add to Collection
Article Clinical Neurology

Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity A Randomized Clinical Trial

Keith Vossel et al.

Summary: The study demonstrated that treatment with levetiracetam improved spatial memory and executive function tasks in patients with Alzheimer's disease and epileptiform activity, suggesting the need for further assessment of antiseizure approaches in AD.

JAMA NEUROLOGY (2021)

Add to Collection
Article Clinical Neurology

Disease progression in Parkinson's disease patients with subjective cognitive complaint

Lin-Lin Han et al.

Summary: Parkinson's disease patients with subjective cognitive complaint (PD-SCC) exhibit faster deterioration of depression and quality of life than those with normal cognition. Subjective cognitive complaint may serve as an indicator of initial attention and executive function decline in Parkinson's disease.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)

Add to Collection
Review Clinical Neurology

Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease - A cochrane review summary with commentary

Tobias Loetscher

Summary: Cognitive training did not show clear improvements in cognition for individuals with Parkinson's disease, suggesting a need for larger and more methodologically rigorous trials in this population.

NEUROREHABILITATION (2021)

Add to Collection
Article Medicine, General & Internal

Parkinson disease-associated cognitive impairment

Dag Aarsland et al.

Summary: Cognitive impairment is common in Parkinson disease patients, with varying degrees of severity, emphasizing the importance of early identification and treatment.

NATURE REVIEWS DISEASE PRIMERS (2021)

Add to Collection
Review Medicine, General & Internal

A Scoping Review of Neuromodulation Techniques in Neurodegenerative Diseases: A Useful Tool for Clinical Practice?

Fabio Marson et al.

Summary: Neuromodulation techniques show promising results in targeting cognitive impairment in neurodegenerative diseases, but further robust studies are needed to evaluate their clinical efficacy and limitations.

MEDICINA-LITHUANIA (2021)

Add to Collection
Review Clinical Neurology

Prevalence and clinical aspects of mild cognitive impairment in Parkinson's disease: A meta-analysis

Chiara Baiano et al.

MOVEMENT DISORDERS (2020)

Add to Collection
Review Clinical Neurology

Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018)

Jean-Pascal Lefaucheur et al.

CLINICAL NEUROPHYSIOLOGY (2020)

Add to Collection
Review Geriatrics & Gerontology

Cognitive Impairment and Dementia in Parkinson Disease

Jennifer G. Goldman et al.

CLINICS IN GERIATRIC MEDICINE (2020)

Add to Collection
Article Clinical Neurology

Efficacy and safety of 5-hydroxytryptophan on depression and apathy in Parkinson's disease: a preliminary finding

M. Meloni et al.

EUROPEAN JOURNAL OF NEUROLOGY (2020)

Add to Collection
Review Clinical Neurology

Non-pharmacological management of cognitive impairment in Parkinson's disease

Monika Pupikova et al.

JOURNAL OF NEURAL TRANSMISSION (2020)

Add to Collection
Article Clinical Neurology

Dynamics of impulsive-compulsive behaviors in early Parkinson's disease: a prospective study

Vladana Markovic et al.

JOURNAL OF NEUROLOGY (2020)

Add to Collection
Article Clinical Neurology

Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults

Shama Karanth et al.

JAMA NEUROLOGY (2020)

Add to Collection
Review Clinical Neurology

Incentive-driven decision-making networks in de novo and drug-treated Parkinson's disease patients with impulsive-compulsive behaviors: A systematic review of neuroimaging studies

Alice Martini et al.

PARKINSONISM & RELATED DISORDERS (2020)

Add to Collection
Review Clinical Neurology

Efficacy and safety of atypical antipsychotics for psychosis in Parkinson's disease: A systematic review and Bayesian network meta-analysis

Ryo Iketani et al.

PARKINSONISM & RELATED DISORDERS (2020)

Add to Collection
Review Neurosciences

Non-invasive Brain Stimulation for Gambling Disorder: A Systematic Review

Chiara Zucchella et al.

FRONTIERS IN NEUROSCIENCE (2020)

Add to Collection
Article Clinical Neurology

Telemedicine and Virtual Reality for Cognitive Rehabilitation: A Roadmap for the COVID-19 Pandemic

Elisa Mantovani et al.

FRONTIERS IN NEUROLOGY (2020)

Add to Collection
Article Clinical Neurology

A trial of buspirone for anxiety in Parkinson's disease: Safety and tolerability

Ruth B. Schneider et al.

PARKINSONISM & RELATED DISORDERS (2020)

Add to Collection
Article Clinical Neurology

Unmet needs in Parkinson disease: Motor and non-motor

Peter A. LeWitt et al.

PARKINSONISM & RELATED DISORDERS (2020)

Add to Collection
Review Clinical Neurology

Is Braak staging valid for all types of Parkinson's disease?

Kurt A. Jellinger

JOURNAL OF NEURAL TRANSMISSION (2019)

Add to Collection
Article Clinical Neurology

Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial

C. R. A. Silveira et al.

BMC NEUROLOGY (2019)

Add to Collection
Review Clinical Neurology

Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms?

Jose Alexandre S. Crippa et al.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2019)

Add to Collection
Review Clinical Neurology

Mild cognitive impairment in Parkinson's disease

Saul Martinez-Horta et al.

JOURNAL OF NEURAL TRANSMISSION (2019)

Add to Collection
Article Clinical Neurology

Cognitive complaints in Parkinson's disease patients: from subjective cognitive complaints to dementia and affective disorders

Raquel P. Barbosa et al.

JOURNAL OF NEURAL TRANSMISSION (2019)

Add to Collection
Review Psychology, Clinical

(Neuro)Psychological Interventions for Non-Motor Symptoms in the Treatment of Patients with Parkinson's Disease: a Systematic Umbrella Review

Hanna Kampling et al.

NEUROPSYCHOLOGY REVIEW (2019)

Add to Collection
Review Behavioral Sciences

Depression in neurodegenerative diseases: Common mechanisms and current treatment options

Ciaran P. C. Galts et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)

Add to Collection
Review Clinical Neurology

Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review

Klaus Seppi et al.

MOVEMENT DISORDERS (2019)

Add to Collection
Review Psychology, Developmental

The impact of cognitive interventions on cognitive symptoms in idiopathic Parkinson's disease: a systematic review

Marianne Couture et al.

AGING NEUROPSYCHOLOGY AND COGNITION (2019)

Add to Collection
Review Clinical Neurology

Global Scales for Cognitive Screening in Parkinson's Disease: Critique and Recommendations

Matej Skorvanek et al.

MOVEMENT DISORDERS (2018)

Add to Collection
Article Neurosciences

Frequency and Correlates of Subjective Memory Complaints in Parkinson's Disease with and without Mild Cognitive Impairment: Data from the Parkinson's Disease Cognitive Impairment Study

Roberta Baschi et al.

JOURNAL OF ALZHEIMERS DISEASE (2018)

Add to Collection
Review Clinical Neurology

Updating the recommendations for treatment of tardive syndromes: A systematic review of new evidence and practical treatment algorithm

Roongroj Bhidayasiri et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)

Add to Collection
Editorial Material Medicine, General & Internal

Pimavanserin evaluated by the FDA

Paul Webster

LANCET (2018)

Add to Collection
Review Clinical Neurology

Risk factors for non-motor symptoms in Parkinson's disease

Johan Marinus et al.

LANCET NEUROLOGY (2018)

Add to Collection
Article Clinical Neurology

Longitudinal analysis of impulse control disorders in Parkinson disease

Jean-Christophe Corvol et al.

NEUROLOGY (2018)

Add to Collection
Article Clinical Neurology

Subjective cognitive decline and risk of MCI The Mayo Clinic Study of Aging

Argonde C. van Harten et al.

NEUROLOGY (2018)

Add to Collection
Article Neurosciences

Citalopram restores short-term memory deficit and non-cognitive behaviors in APP/PS1 mice while halting the advance of Alzheimer's disease-like pathology

Qin Zhang et al.

NEUROPHARMACOLOGY (2018)

Add to Collection
Review Clinical Neurology

Frequency of mood and anxiety fluctuations in Parkinson's disease patients with motor fluctuations: A systematic review

Rachel M. J. van der Velden et al.

MOVEMENT DISORDERS (2018)

Add to Collection
Article Neurosciences

Importance of Balance-Gait Disorder as a Risk Factor for Cognitive Impairment, Dementia and Related Non-Motor Symptoms in Parkinson's Disease

David Gordon Lichter et al.

JOURNAL OF PARKINSONS DISEASE (2018)

Add to Collection
Review Clinical Neurology

Impulse Control Disorder in Parkinson's Disease: A Meta-Analysis of Cognitive, Affective, and Motivational Correlates

Alice Martini et al.

FRONTIERS IN NEUROLOGY (2018)

Add to Collection
Review Clinical Neurology

Dopaminergic Neurotransmission in Patients With Parkinson's Disease and Impulse Control Disorders: A Systematic Review and Meta-Analysis of PET and SPECT Studies

Alice Martini et al.

FRONTIERS IN NEUROLOGY (2018)

Add to Collection
Review Clinical Neurology

The Multidisciplinary Approach to Alzheimer's Disease and Dementia. A Narrative Review of Non-Pharmacological Treatment

Chiara Zucchella et al.

FRONTIERS IN NEUROLOGY (2018)

Add to Collection
Article Clinical Neurology

Cognitive complaint in early Parkinson's disease: A pilot study

J. Dupouy et al.

ACTA NEUROLOGICA SCANDINAVICA (2018)

Add to Collection
Article Clinical Neurology

Epidemiology of Parkinson's disease

Ole-Bjorn Tysnes et al.

JOURNAL OF NEURAL TRANSMISSION (2017)

Add to Collection
Article Clinical Neurology

Stability of mild cognitive impairment in newly diagnosed Parkinson's disease

Rachael A. Lawson et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)

Add to Collection
Review Clinical Neurology

Hallucinations and the spectrum of psychosis in Parkinson's disease

Karen Frei et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)

Add to Collection
Article Clinical Neurology

Anhedonia and its correlation with clinical aspects in Parkinson's disease

Hiroshi Nagayama et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)

Add to Collection
Article Clinical Neurology

Mild Cognitive Impairment as a Risk Factor for Parkinson's Disease Dementia

Jeroen Hoogland et al.

MOVEMENT DISORDERS (2017)

Add to Collection
Review Clinical Neurology

Cognitive decline in Parkinson disease

Dag Aarsland et al.

NATURE REVIEWS NEUROLOGY (2017)

Add to Collection
Review Clinical Neurology

The psychosis spectrum in Parkinson disease

Dominic H. Ffytche et al.

NATURE REVIEWS NEUROLOGY (2017)

Add to Collection
Review Neurosciences

Non-motor features of Parkinson disease

Anthony H. V. Schapira et al.

NATURE REVIEWS NEUROSCIENCE (2017)

Add to Collection
Article Clinical Neurology

Diagnosing mild cognitive impairment in Parkinson's disease: which tests perform best in the Italian population?

Angela Federico et al.

NEUROLOGICAL SCIENCES (2017)

Add to Collection
Article Clinical Neurology

Natural course of mild cognitive impairment in Parkinson disease A 5-year population-based study

Kenn Freddy Pedersen et al.

NEUROLOGY (2017)

Add to Collection
Review Behavioral Sciences

Non-invasive brain stimulation in Parkinson's disease: Exploiting crossroads of cognition and mood

Lars Dinkelbach et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)

Add to Collection
Review Clinical Neurology

Imaging the Etiology of Apathy, Anxiety, and Depression in Parkinson's Disease: Implication for Treatment

Stephane Thobois et al.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2017)

Add to Collection
Article Behavioral Sciences

Neuroprotective effects of ceftriaxone treatment on cognitive and neuronal deficits in a rat model of accelerated senescence

Maria A. Tikhonova et al.

BEHAVIOURAL BRAIN RESEARCH (2017)

Add to Collection
Review Neurosciences

Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?

M. A. Qamar et al.

NPJ PARKINSONS DISEASE (2017)

Add to Collection
Article Psychology, Clinical

Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia

Ivan Galtier et al.

JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2016)

Add to Collection
Article Clinical Neurology

Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings

Lama M. Chahine et al.

MOVEMENT DISORDERS (2016)

Add to Collection
Review Clinical Neurology

Worldwide Differences in Regulations of Clozapine Use

Jimmi Nielsen et al.

CNS DRUGS (2016)

Add to Collection
Article Clinical Neurology

Emotional manifestations of PD: Neurobiological basis

Anna Castrioto et al.

MOVEMENT DISORDERS (2016)

Add to Collection
Article Clinical Neurology

The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations

Raul Martinez-Fernandez et al.

MOVEMENT DISORDERS (2016)

Add to Collection
Review Clinical Neurology

Prevalence of anxiety in Parkinson's disease: A systematic review and meta-analysis

Martijn P. G. Broen et al.

MOVEMENT DISORDERS (2016)

Add to Collection
Article Clinical Neurology

Epidemiology of Parkinson Disease

Andrea Lee et al.

NEUROLOGIC CLINICS (2016)

Add to Collection
Article Clinical Neurology

Multifocal repetitive TMS for motor and mood symptoms of Parkinson disease A randomized trial

Miroslaw Brys et al.

NEUROLOGY (2016)

Add to Collection
Article Neurosciences

High-Frequency Repetitive Transcranial Magnetic Stimulation Can Improve Depression in Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Study

Attila Makkos et al.

NEUROPSYCHOBIOLOGY (2016)

Add to Collection
Review Clinical Neurology

Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms

Valeria D. Felice et al.

PARKINSONISM & RELATED DISORDERS (2016)

Add to Collection
Article Clinical Neurology

Memantine and Cognition in Parkinson's Disease Dementia/Dementia With Lewy Bodies: A Meta-Analysis

Laura Brennan et al.

MOVEMENT DISORDERS CLINICAL PRACTICE (2016)

Add to Collection
Article Clinical Neurology

Cognitive function in the early phase of Parkinson's disease, a five-year follow-up

M. E. Domellof et al.

ACTA NEUROLOGICA SCANDINAVICA (2015)

Add to Collection
Article Clinical Neurology

Qualitative Characteristics of Depression in Parkinson's Patients and Controls

Cleo Kritzinger et al.

BEHAVIOURAL NEUROLOGY (2015)

Add to Collection
Review Clinical Neurology

Parkinson's disease dementia: a neural networks perspective

James Gratwicke et al.

BRAIN (2015)

Add to Collection
Article Geriatrics & Gerontology

Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort

Peter Hobson et al.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2015)

Add to Collection
Review Clinical Neurology

Cognitive and neuroanatomical correlates of neuropsychiatric symptoms in Parkinson's disease: A systematic review

Hamad Alzahrani et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)

Add to Collection
Article Medicine, General & Internal

Parkinson's disease

Lorraine V. Kalia et al.

LANCET (2015)

Add to Collection
Article Clinical Neurology

Prediagnostic presentations of Parkinson's disease in primary care: a case-control study

Anette Schrag et al.

LANCET NEUROLOGY (2015)

Add to Collection
Article Clinical Neurology

Resting-State Frontostriatal Functional Connectivity in Parkinson's Disease-Related Apathy

Hugo Cesar Baggio et al.

MOVEMENT DISORDERS (2015)

Add to Collection
Article Clinical Neurology

Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease

Daniel Weintraub et al.

MOVEMENT DISORDERS (2015)

Add to Collection
Review Clinical Neurology

MDS research criteria for prodromal Parkinson's disease

Daniela Berg et al.

MOVEMENT DISORDERS (2015)

Add to Collection
Article Geriatrics & Gerontology

Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease

Joannee Zumkehr et al.

NEUROBIOLOGY OF AGING (2015)

Add to Collection
Article Clinical Neurology

Prognostic factors for early mortality in Parkinson's disease

Linda P. Oosterveld et al.

PARKINSONISM & RELATED DISORDERS (2015)

Add to Collection
Review Clinical Neurology

Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis

Hui-Fu Wang et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)

Add to Collection
Article Clinical Neurology

Subjective Cognitive Complaints in Parkinson Disease Without Dementia: A Preliminary Study

Daniel P. Koster et al.

APPLIED NEUROPSYCHOLOGY-ADULT (2015)

Add to Collection
Article Clinical Neurology

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

Frank Jessen et al.

ALZHEIMERS & DEMENTIA (2014)

Add to Collection
Article Clinical Neurology

Subthreshold depression and subjective cognitive complaints in Parkinson's disease

G. Santangelo et al.

EUROPEAN JOURNAL OF NEUROLOGY (2014)

Add to Collection
Article Clinical Neurology

Health-related quality of life in early Parkinson's disease: The impact of nonmotor symptoms

Gordon W. Duncan et al.

MOVEMENT DISORDERS (2014)

Add to Collection
Article Clinical Neurology

Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia

Roberta Biundo et al.

PARKINSONISM & RELATED DISORDERS (2014)

Add to Collection
Article Medicine, General & Internal

Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study

Kajsa Stubendorff et al.

BMJ OPEN (2014)

Add to Collection
Article Geriatrics & Gerontology

Classification and Epidemiology of MCI

Rosebud Roberts et al.

CLINICS IN GERIATRIC MEDICINE (2013)

Add to Collection
Article Clinical Neurology

Psychosocial risk factors, pre-motor symptoms and first-time hospitalization with Parkinson's disease: a prospective cohort study

A. J. Clark et al.

EUROPEAN JOURNAL OF NEUROLOGY (2013)

Add to Collection
Article Clinical Neurology

The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort

Caroline H. Williams-Gray et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)

Add to Collection
Article Clinical Neurology

Evolution of mild cognitive impairment in Parkinson disease

M. Broeders et al.

NEUROLOGY (2013)

Add to Collection
Review Neurosciences

The Role of Oxidative Stress in Parkinson's Disease

Vera Dias et al.

JOURNAL OF PARKINSONS DISEASE (2013)

Add to Collection
Article Neurosciences

Pacific Northwest Udall Center of Excellence Clinical Consortium: Study Design and Baseline Cohort Characteristics

Brenna A. Cholerton et al.

JOURNAL OF PARKINSONS DISEASE (2013)

Add to Collection
Review Clinical Neurology

Neuroinflammation and Non-motor Symptoms: The Dark Passenger of Parkinson's Disease?

Christopher J. Barnum et al.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2012)

Add to Collection
Article Geriatrics & Gerontology

Cognitive Impairment in Parkinson Disease: Impact on Quality of Life, Disability, and Caregiver Burden

Iracema Leroi et al.

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2012)

Add to Collection
Article Clinical Neurology

Neurocognitive and atrophic patterns in Parkinson's disease based on subjective memory complaints

Jin Yong Hong et al.

JOURNAL OF NEUROLOGY (2012)

Add to Collection
Article Clinical Neurology

The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life

Angelo Antonini et al.

JOURNAL OF NEUROLOGY (2012)

Add to Collection
Article Clinical Neurology

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

Irene Litvan et al.

MOVEMENT DISORDERS (2012)

Add to Collection
Article Clinical Neurology

Synuclein deposition and non-motor symptoms in Parkinson disease

Kurt A. Jellinger

JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)

Add to Collection
Review Clinical Neurology

Anhedonia in Parkinson's Disease: A Systematic Review of the Literature

Francesca Assogna et al.

MOVEMENT DISORDERS (2011)

Add to Collection
Review Clinical Neurology

MDS Task Force on Mild Cognitive Impairment in Parkinson's Disease: Critical Review of PD-MCI

Irene Litvan et al.

MOVEMENT DISORDERS (2011)

Add to Collection
Article Psychiatry

Prediction of Dementia by Subjective Memory Impairment Effects of Severity and Temporal Association With Cognitive Impairment

Frank Jessen et al.

ARCHIVES OF GENERAL PSYCHIATRY (2010)

Add to Collection
Article Clinical Neurology

Relationships between age and late progression of Parkinson's disease: a clinico-pathological study

Peter A. Kempster et al.

BRAIN (2010)

Add to Collection
Article Clinical Neurology

Cognitive complaints in Parkinson's disease: its relationship with objective cognitive decline

Kathy Dujardin et al.

JOURNAL OF NEUROLOGY (2010)

Add to Collection
Article Clinical Neurology

Epidemiology of psychosis in Parkinson's disease

Gilles Fenelon et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)

Add to Collection
Article Neurosciences

Staging of serotonergic dysfunction in Parkinson's Disease: An in vivo 11C-DASB PET study

Marios Politis et al.

NEUROBIOLOGY OF DISEASE (2010)

Add to Collection
Article Clinical Neurology

Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo

J. C. Klein et al.

NEUROLOGY (2010)

Add to Collection
Article Clinical Neurology

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

Caroline H. Williams-Gray et al.

BRAIN (2009)

Add to Collection
Review Clinical Neurology

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

K. Ray Chaudhuri et al.

LANCET NEUROLOGY (2009)

Add to Collection
Article Clinical Neurology

Randomized Controlled Trial of Memantine in Dementia Associated with Parkinson's Disease

Iracema Leroi et al.

MOVEMENT DISORDERS (2009)

Add to Collection
Article Clinical Neurology

Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort

E. Y. Uc et al.

NEUROLOGY (2009)

Add to Collection
Article Clinical Neurology

The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

Mariese A. Hely et al.

MOVEMENT DISORDERS (2008)

Add to Collection
Article Clinical Neurology

Dementia and survival in Parkinson disease - A 12-year population study

T. C. Buter et al.

NEUROLOGY (2008)

Add to Collection
Review Clinical Neurology

Clinical diagnostic criteria for dementia associated with Parkinson's disease

Murat Emre et al.

MOVEMENT DISORDERS (2007)

Add to Collection
Review Neurosciences

Revenge of the sit: How lifestyle impacts neuronal and cognitive health through molecular systems that interface energy metabolism with neuronal plasticity

Shoshanna Vaynman et al.

JOURNAL OF NEUROSCIENCE RESEARCH (2006)

Add to Collection
Review Geriatrics & Gerontology

Staging of brain pathology related to sporadic Parkinson's disease

H Braak et al.

NEUROBIOLOGY OF AGING (2003)

Add to Collection
Article Clinical Neurology

Prevalence and characteristics of dementia in Parkinson disease - An 8-year prospective study

D Aarsland et al.

ARCHIVES OF NEUROLOGY (2003)

Add to Collection
Article Psychology, Clinical

Relation between clinical characteristics of Parkinson's disease and cognitive decline

JJ Locascio et al.

JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2003)

Add to Collection
Article Geriatrics & Gerontology

Exercise, experience and the aging brain

JD Churchill et al.

NEUROBIOLOGY OF AGING (2002)

Add to Collection
Article Clinical Neurology

Nonmotor fluctuations in Parkinson's disease -: Frequent and disabling

T Witjas et al.

NEUROLOGY (2002)

Add to Collection
Article Clinical Neurology

A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease

TA Hughes et al.

NEUROLOGY (2000)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.